Code of Federal Regulations (Last Updated: November 8, 2024) |
Title 21 - Food and Drugs |
Chapter I - Food and Drug Administration, Department of Health and Human Services |
SubChapter E - Animal Drugs, Feeds, and Related Products |
Part 558 - New Animal Drugs for Use in Animal Feeds |
Subpart B - Specific New Animal Drugs for Use in Animal Feeds |
§ 558.78 - Bacitracin zinc.
-
§ 558.78 Bacitracin zinc.
(a) Specifications. Type A medicated articles containing bacitracin zinc equivalent to 10, 25, 40, or 50 grams per pound bacitracin.
(b) ApprovalsSponsor. See No. 054771 in § 510.600(c) of this chapter.
(c) Related tolerances. See § 556.70 of this chapter.
(d) Conditions of use.
(1) It is used as follows:
Bacitracin zinc in grams per ton Combinations in grams per ton Indications for use Limitations Sponsor (i) 4 to 50 Chickens: for increased rate of weight gain and improved feed efficiency Growing chickens 054771 (ii) 4 to 50 Turkeys and pheasants: for increased rate of weight gain and improved feed efficiency Growing turkeys and pheasants 054771 (iii) 5 to 20 Quail; for increased rate of weight gain and improved feed efficiency Growing quail; feed as the Type C feed to starting quail through 5 weeks of age 054771 (iv) 10 to 25 Laying chickens; improved feed efficiency and increased egg production 054771 (v) 10 to 50 Swine; increased rate of weight gain and improved feed efficiency Growing and finishing swine 054771 (vi) 20 Growing-finishing swine; increased rate of weight gain In Type C feed 054771 (vii) 20 to 40 Growing-finishing swine; improved feed efficiency ......do 054771 (2) It is used in feed for growing cattle at 35 to 70 milligrams per head per day as follows:
(i) To aid in stimulating growth and improving feed efficiency.
(ii) For increased rate of weight gain and improved feed efficiency; see sponsor 054771.
(3) Bacitracin zinc may also be used in combination with:
(i) Amprolium and ethopabate as in § 558.58.
(ii) Clopidol as in § 558.175.
(iii) Decoquinate as in § 558.195.
(iv) Lasalocid as in § 558.311.
(v) Monensin as in § 558.355.
(vi) Naracin as in § 558.363.
(vii) Nicarbazin as in § 558.366.
(viii) Robenidine as in § 558.515.
(ix) Salinomycin as in § 558.550.
[41 FR 10994, Mar. 15, 1976]